Leading COVID-19 drugs, therapies and vaccines in development by early results 2020

As of April 2020, a number of treatments and vaccines were in development worldwide to treat COVID-19. This statistic shows the expected early result timelines for the most promising drugs, therapies and vaccines currently in development for COVID-19 (coronavirus) as of April 21, 2020. Early results are expected within the next three months for the mRNA 1273 vaccine by Moderna and NIAID, as well as for Novamax' NVX-CoV2373 vaccine. The development of vaccines is of special interest as only a safe and effective vaccine is expected to stop the spread of the novel coronavirus permanently.

Early result timelines for most promising COVID-19 treatments and vaccines in development as of April 21, 2020

You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

April 2020

Region

Worldwide

Survey time period

as of April 21, 2020

Supplementary notes

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.